This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hypersensitivity  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Narrowband (NB) UV-B (311-313 nm) phototherapy was recently reported to be an effective adjunctive treatment for moderate to severe chronic atopic dermatitis (AD) and was found to be more effective than irradiation with broadband UV-A (320-400 nm) or visible light (>400 nm).¹ We herein report the findings of our half-side comparison study in patients with AD on the efficacy of NB UV-B vs medium-dose UV-A1 (340-400 nm), a specific form of UV-A phototherapy that in recent years was introduced for the treatment of AD.²

Patients and Methods

Nine patients (6 women, 3 men; median age, 27 years; age range, 23-41 years) with chronic AD (median disease duration, 22 years; range, 2-33 years) according to the criteria published by Hanifin and Rajka³ were enrolled in the study after giving their informed consent. Exclusion criteria included local treatment with corticosteroids within the last 2 weeks or systemic treatment with antibiotics, corticosteroids, or other immunosuppressive drugs . . . [Full Text of this Article]

Results

Comment


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atopic and non-atopic eczema
Brown and Reynolds
BMJ 2006;332:584-588.
FULL TEXT  

Chronic Atopic Dermatitis: Treat with Narrowband UVB or UVA1?
Journal Watch Dermatology 2003;2003:2-2.
FULL TEXT